Overcoming Barriers to Statin Adherence

Arden Bui, PharmD Candidate 2021; Juwon Kwon, PharmD; Jennifer Kim, PharmD, BCPS, BCACP, CPP; Austin Lucas, PharmD

Disclosures

US Pharmacist. 2019;44(6):19-22. 

In This Article

Conclusion

Although the number of patients indicated to receive statin therapy continues to increase, use remains suboptimal owing to concerns about tolerability and adherence. Meanwhile, CVD remains the leading cause of morbidity and mortality. Pharmacists play a crucial role in reducing CVD risk by improving adherence to statins.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....